These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1398633)

  • 21. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR; Johnson CE; Conlon PF; Weg JG
    J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained release oral aminophylline in patients with airflow obstruction.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    Thorax; 1981 Apr; 36(4):303-7. PubMed ID: 7025336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease.
    Barberá JA; Reyes A; Roca J; Montserrat JM; Wagner PD; Rodríguez-Roisin R
    Am Rev Respir Dis; 1992 Jun; 145(6):1328-33. PubMed ID: 1595998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of enoxacin on theophylline pharmacokinetics].
    Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral aminophylline therapy. Increased dosage requirements in children.
    Zaske DE; Miller KW; Strem EL; Austrian S; Johnson PB
    JAMA; 1977 Apr; 237(14):1453-5. PubMed ID: 576637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
    Cazzola M; Matera MG; Paternò E; Scaglione F; Santangelo G; Rossi F
    J Chemother; 1991 Aug; 3(4):240-4. PubMed ID: 1779258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminophylline dosage in acute severe asthma.
    Gleeson JG; Price JF
    Eur J Pediatr; 1989 Apr; 148(6):577-8. PubMed ID: 2744023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theophylline concentrations in asthmatic patients after administration of aminophylline.
    Kordash TR; Van Dellen RG; McCall JT
    JAMA; 1977 Jul; 238(2):139-41. PubMed ID: 577283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM; Hudson SA; Jefferson GC
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmogenic effects of aminophylline during halothane anesthesia in experimental animals.
    Stirt JA; Berger JM; Ricker SM; Sullivan SF
    Anesth Analg; 1980 Jun; 59(6):410-6. PubMed ID: 7189977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined use of intravenous salbutamol and aminophylline on cardiac rhythm in chronic obstructive lung disease.
    Bigi R; Camerone G; Corradetti C; Durante V; Occhi G; Toloni V
    Respiration; 1987; 51(2):119-26. PubMed ID: 3589176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
    Silins RA; Butcher MA; Marlin GE
    Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodynamic and therapeutic significance of plasma atrial natriuretic peptide in chronic lung diseases].
    Hiraga T
    Hokkaido Igaku Zasshi; 1991 Mar; 66(2):201-14. PubMed ID: 1829435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 39. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.